Table 2.
Spectrum of PIDs, 1979–2020.
PID category | N |
---|---|
Immunodeficiencies affecting cellular and humoral immunity | 36 (30.3%) |
Severe Combined Immunodeficiency Disease | 22 |
Combined T and B cell deficiencies | 2 |
Hyper IgM Syndrome | 7 |
DOCK8 deficiency | 2 |
T cell deficiency—undefined | 3 |
Combined immunodeficiencies with associated or syndromic features | 21 (17.6%) |
Wiskott–Aldrich Syndrome | 10 |
Ataxia telangiectasia | 1 |
Di George/velocardio-facial Syndrome | 5 |
Hyper-IgE Syndrome | 5 |
Predominant antibody deficiencies | 24 (20.2%) |
X-linked Agammaglobulinemia | 17 |
Common variable immune deficiency | 3 |
Selective IgA deficiency | 2 |
CD19 deficiency | 1 |
Undefined hypo-gammaglobulinemia | 1 |
Disease of immune dysregulation | 13 (10.9%) |
Hemophagocytic Lymphohistiocytosis | 6 |
Chediak-Higashi Syndrome | 3 |
Griscelli Syndrome (Type 2) | 1 |
X-linked Lymphoproliferative Disorder | 2 |
XIAP deficiency | 1 |
Congenital defects of phagocyte number or function | 20 (16.8%) |
Congenital Neutropenia | 6 |
Leukocyte Adhesion Deficiency | 1 |
Chronic granulomatous disease | 13 |
Defects in intrinsic and innate immunity | 4 (3.4%) |
IL12RB1 deficiency | 1 |
Chronic Mucocutaneous Syndrome | 3 |
Autoinflammatory disorders | 1 (0.8%) |
Autoinflammatory disorder (NLRC4 mutation) | 1 |